According to a market report by Lucintel, the future of the global asthma spacer market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global asthma spacer market is expected to reach an estimated $1.7 billion by 2030 from $1.3 billion in 2024,at a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are increasing incidence of chronic respiratory diseases and growing understanding of PFO-related complications like cryptogenic stroke, migraines, and recurrent decompression sickness.
A more than 150-page report to understand trends, opportunity and forecast in asthma spacer market to 2030 by spacer type (volumatic, aerochamber, inspirease, optichamber, and others), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the spacer type category, volumatic will remain the largest segment over the forecast period.
Within the distribution channel category, retail pharmacy will remain the largest segment due to the easy accessibility of the product from the local retail pharmacy.
Download sample by clicking on asthma spacer market
In terms of regions, North America will remain the largest region over the forecast period due to rise in the patient pool for asthma in the region.
Trudell Medical, PARI Respiratory Equipment, Koninklijke Philips, GlaxoSmithKline, Lupin, Visiomed Group, Cipla, Clement Clarke International, Rossmax International, LuckysPharmaare the major suppliers in the asthma spacer market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]To get access of more than 1000 reports at fraction of cost visit Lucintel'sAnalytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Comments on “Lucintel Forecasts the Global Asthma Spacer Market to Reach$1.7 billion by 2030”